Follow
Imesch Patrick
Imesch Patrick
University Hospital Zurich, Department of Gynecology
Verified email at usz.ch
Title
Cited by
Cited by
Year
ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas
EP Samartzis, A Noske, KJ Dedes, D Fink, P Imesch
International journal of molecular sciences 14 (9), 18824-18849, 2013
1952013
Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer
AM Schmidt, P Imesch, D Fink, H Egger
Gynecologic oncology 125 (3), 604-609, 2012
1682012
Loss of ARID1A expression sensitizes cancer cells to PI3K-and AKT-inhibition
EP Samartzis, K Gutsche, KJ Dedes, D Fink, M Stucki, P Imesch
Oncotarget 5 (14), 5295, 2014
1522014
Fatigue–a symptom in endometriosis
A Ramin-Wright, ASK Schwartz, K Geraedts, M Rauchfuss, MM Wölfler, ...
Human reproduction 33 (8), 1459-1465, 2018
1392018
Loss of ARID1A/BAF250a-expression in endometriosis: a biomarker for risk of carcinogenic transformation?
EP Samartzis, N Samartzis, A Noske, A Fedier, R Caduff, KJ Dedes, ...
Modern Pathology 25 (6), 885-892, 2012
1132012
Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro
R Koppensteiner, EP Samartzis, A Noske, A von Teichman, I Dedes, ...
PloS one 9 (6), e100041, 2014
922014
The antibody-mediated targeted delivery of interleukin-10 inhibits endometriosis in a syngeneic mouse model
K Schwager, F Bootz, P Imesch, M Kaspar, E Trachsel, D Neri
Human reproduction 26 (9), 2344-2352, 2011
842011
Endometriosis, especially mild disease: a risk factor for miscarriages
ASK Schwartz, MM Wölfler, V Mitter, M Rauchfuss, F Haeberlin, ...
Fertility and sterility 108 (5), 806-814. e2, 2017
832017
The G protein-coupled estrogen receptor (GPER) is expressed in two different subcellular localizations reflecting distinct tumor properties in breast cancer
EP Samartzis, A Noske, A Meisel, Z Varga, D Fink, P Imesch
PloS one 9 (1), e83296, 2014
782014
Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial
KJ Dedes, TD Szucs, P Imesch, A Fedier, MK Fehr, D Fink
Annals of oncology 18 (9), 1493-1499, 2007
732007
Does endometriosis affect professional life? A matched case-control study in Switzerland, Germany and Austria
ML Sperschneider, MP Hengartner, A Kohl-Schwartz, K Geraedts, ...
BMJ open 9 (1), e019570, 2019
682019
Developmental potential of human oocytes matured in vitro followed by vitrification and activation
P Imesch, D Scheiner, M Xie, D Fink, E Macas, R Dubey, B Imthurn
Journal of Ovarian Research 6, 1-5, 2013
582013
The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells
A Fedier, KJ Dedes, P Imesch, AO Von Bueren, D Fink
International journal of oncology 31 (3), 633-641, 2007
582007
The ENZIAN score as a preoperative MRI-based classification instrument for deep infiltrating endometriosis
L Burla, D Scheiner, EP Samartzis, S Seidel, M Eberhard, D Fink, A Boss, ...
Archives of gynecology and obstetrics 300, 109-116, 2019
572019
Satisfaction with medical support in women with endometriosis
I Lukas, A Kohl-Schwartz, K Geraedts, M Rauchfuss, MM Wölfler, ...
PloS one 13 (11), e0208023, 2018
572018
Disease progression and recurrence in women treated for vulvovaginal intraepithelial neoplasia
MK Fehr, M Baumann, M Mueller, D Fink, S Heinzl, P Imesch, K Dedes
Journal of gynecologic oncology 24 (3), 236-241, 2013
572013
Maltreatment during childhood: a risk factor for the development of endometriosis?
C Liebermann, AS Kohl Schwartz, T Charpidou, K Geraedts, M Rauchfuss, ...
Human reproduction 33 (8), 1449-1458, 2018
552018
The expression of histone deacetylase 1, but not other class I histone deacetylases, is significantly increased in endometriosis
EP Samartzis, A Noske, N Samartzis, D Fink, P Imesch
Reproductive Sciences 20 (12), 1416-1422, 2013
552013
Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin
P Imesch, EP Samartzis, M Schneider, D Fink, A Fedier
Fertility and sterility 95 (5), 1579-1583, 2011
552011
Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells
P Imesch, D Fink, A Fedier
Fertility and sterility 94 (7), 2838-2842, 2010
542010
The system can't perform the operation now. Try again later.
Articles 1–20